2019
DOI: 10.1016/j.bbagrm.2019.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptionally elevation of miR-494 by new ChlA-F compound via a HuR/JunB axis inhibits human bladder cancer cell invasion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 49 publications
0
3
0
Order By: Relevance
“…This miRNA has been identified as an important factor and a promising therapeutic target for lung cancer 8 and muscle-invasive bladder cancer. 9 Moreover, miR-494 is highly expressed in hepatocellular carcinoma (HCC), it may be related to tumor size and stemness markers, and it is a possible therapeutic target and a candidate biomarker for stratification of patients with advanced HCC. 10 Propofol is an intravenous hypnotic agent used to induce and maintain sedation and general anesthesia, and it enhances the inhibitory neurotransmitter gammaaminobutyric acid at the gammaaminobutyric acid A receptor.…”
Section: Introductionmentioning
confidence: 99%
“…This miRNA has been identified as an important factor and a promising therapeutic target for lung cancer 8 and muscle-invasive bladder cancer. 9 Moreover, miR-494 is highly expressed in hepatocellular carcinoma (HCC), it may be related to tumor size and stemness markers, and it is a possible therapeutic target and a candidate biomarker for stratification of patients with advanced HCC. 10 Propofol is an intravenous hypnotic agent used to induce and maintain sedation and general anesthesia, and it enhances the inhibitory neurotransmitter gammaaminobutyric acid at the gammaaminobutyric acid A receptor.…”
Section: Introductionmentioning
confidence: 99%
“…HuR-miR-494. In muscle invasive bladder cancer (MIBC) cells (T24T), the anti-cancerous compound ChlA-F, a novel C8 fluoride derivative of cheliensisin A, increases JUNB mRNA stability in a HuR-dependent manner [ 134 ]. Then, Jun-B promotes miR-494 expression, which, in turn, directly binds and decreases c-Myc mRNA [ 134 ].…”
Section: Aubps Interfering With Mirnas-dependent Regulationmentioning
confidence: 99%
“…A growing body of literature suggests that TP53 mutations in lung cancer are associated with increased resistance to cancer therapy and poorer survival prognosis (6), thus, mutp53 is a promising therapeutic target. Many natural or naturally derived antitumor drugs [curcumin (13), artemisinin (14), capsaicin (15)] have begun to play increasingly important roles in clinical cancer treatment (16).…”
Section: Introductionmentioning
confidence: 99%